Concepedia

Daniel W Lee

DW

10

Publications

4.8K

Citations

10

H-Index

1988

Active since

Affiliations

National Cancer Institute(Current)

National Institutes of Health

University of Virginia

National Institutes of Health Clinical Center

Stanford University

Daniel W Lee is an author at National Cancer Institute specializing in medicine, immunology, and health sciences.

Top concepts

Publications per year

1988–2022

10

Publications

10

T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial

Daniel W Lee, James N. Kochenderfer, Maryalice Stetler‐Stevenson et al. · The Lancet · 2014 · 2.9K citations

, , +9

CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy

Terry J. Fry, Nirali N. Shah, Rimas J. Orentas et al. · Nature Medicine · 2017 · 1.3K citations · Full text

, , +9

Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune effector cell-related adverse events

Marcela V. Maus, S. Alexander, Michael R. Bishop et al. · Journal for ImmunoTherapy of Cancer · 2020 · 256 citations · Full text

, , +18

Impact of cytokine release syndrome on cardiac function following CD19 CAR-T cell therapy in children and young adults with hematological malignancies

Haneen Shalabi, Vandana Sachdev, Amita Kulshreshtha et al. · Journal for ImmunoTherapy of Cancer · 2020 · 97 citations · Full text

Efficacy of second CAR-T (CART2) infusion limited by poor CART expansion and antigen modulation

Elizabeth M. Holland, John C. Molina, Kniya DéDé et al. · Journal for ImmunoTherapy of Cancer · 2022 · 53 citations · Full text

Rows per page

1–5 of 10